Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 4, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020
Market Capitalization	16,646	28,166	-	-	-	-
Enterprise Value	15,059	28,105	-	-	-	-
Last Close Price	183.21	310.00	-	-	-	-
PE Ratio	43.06	89.70	-	-	-	-
PS Ratio	4.70	9.34	-	-	-	-
PB Ratio	3.58	6.43	-	-	-	-
P/TBV Ratio	4.43	8.06	-	-	-	-
P/FCF Ratio	-	187.66	-	-	-	-
P/OCF Ratio	-	143.33	-	-	-	-
EV/Sales Ratio	4.26	9.32	-	-	-	-
EV/EBITDA Ratio	29.58	69.86	-	-	-	-
EV/EBIT Ratio	31.98	71.73	-	-	-	-
EV/FCF Ratio	-	187.26	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.05	1.01	1.14	-
Debt / EBITDA Ratio	0.12	0.17	0.15	2.20	2.33	-
Debt / FCF Ratio	-	0.49	0.19	0.78	1.29	-
Asset Turnover	-	0.88	2.07	2.00	-	-
Inventory Turnover	-	221.73	-	-	-	-
Quick Ratio	-	4.47	0.96	0.53	0.56	-
Current Ratio	-	4.68	1.10	0.96	0.67	-
Return on Equity (ROE)	-	12.21%	32.14%	43.48%	-	-
Return on Assets (ROA)	-	7.11%	16.46%	7.90%	-	-
Return on Capital (ROIC)	-	8.72%	26.37%	14.96%	-	-
Return on Capital Employed (ROCE)	-	8.80%	26.80%	21.70%	47.30%	-
Earnings Yield	2.98%	1.11%	-	-	-	-
FCF Yield	-	0.53%	-	-	-	-
Buyback Yield / Dilution	-73.68%	-13.04%	-3.92%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.